Insulin Resistance and Lipid Metabolism Dynamics

Insulin resistance arises when target tissues such as skeletal muscle, adipose tissue and the liver fail to respond adequately to circulating insulin. This impairment disrupts the delicate balance of lipid uptake, utilisation and storage, leading to elevated free fatty acids, ectopic fat deposition and dyslipidaemia. In the liver, heightened lipogenesis and reduced fatty acid oxidation combine to drive steatosis, whilst in adipose tissue increased lipolysis further elevates circulating lipid levels. These metabolic perturbations not only contribute to the development of type 2 diabetes but also underpin cardiovascular risk through the formation of atherogenic lipid profiles. Research into the signalling pathways downstream of the insulin receptor has pinpointed defects in the PI3K–Akt axis and alterations in transcriptional regulators of lipid synthesis. Clinically, simple biomarkers derived from routine lipid panels—such as the ratio of triglycerides to high-density lipoprotein cholesterol—have gained traction as surrogate indicators of insulin sensitivity. A comprehensive understanding of these dynamics is essential to inform both preventive strategies and targeted therapies in the global fight against metabolic syndrome and its complications.

Research from Nature Portfolio

Recent studies have illuminated the complex relationship between lipid ratios and diabetes risk. One investigation in an adult Japanese cohort demonstrated a J-shaped association between the baseline triglyceride-to-HDL cholesterol ratio and incident type 2 diabetes over a five-year follow-up. Below a threshold value, changes in the ratio appeared neutral, whereas values above the inflection point conferred progressively higher diabetes risk, suggesting non-linear dynamics in lipid-driven metabolic stress. In paediatric populations, analyses of overweight and obese children have confirmed that elevated triglyceride-to-HDL cholesterol ratios correlate significantly with quantified measures of insulin resistance. In this group, rising ratio tertiles were accompanied by increased fasting insulin and features of metabolic syndrome, supporting the ratio’s utility as an accessible screening tool in young individuals at high risk of metabolic impairment.

Insulin Resistance and Lipid Metabolism Dynamics publication trend

The graph below shows the total number of articles in insulin resistance and lipid metabolism dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Insulin resistance: A physiological state in which cells exhibit diminished responsiveness to insulin, impairing glucose uptake and metabolic regulation.

Lipid metabolism: The processes governing the synthesis, transport, utilisation and storage of lipids, including fatty acids, triglycerides and cholesterol.

Triglyceride-to-HDL cholesterol ratio: A calculated index obtained by dividing plasma triglyceride concentration by HDL cholesterol concentration, used as a surrogate marker for insulin sensitivity.

TyG Index: A composite marker combining triglyceride and fasting glucose levels to estimate insulin resistance in clinical and research settings.

Atherogenic dyslipidaemia: A lipid profile characterised by elevated triglycerides, low HDL cholesterol and often small dense LDL particles, associated with heightened cardiovascular risk.

References

1. Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese. Scientific Reports (2023).
2. Triglyceride to HDL-C Ratio is Associated with Insulin Resistance in Overweight and Obese Children. Scientific Reports (2017).
3. Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10. Cardiovascular Diabetology (2023).
4. A longitudinal study on the impact of the TyG Index and TG/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes. Lipids in Health and Disease (2024).
5. Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance. Nutrients (2023).
6. The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance. Biomedicines (2024).